The Future of Giving: Empowering Young Philanthropists to Accelerate a Cure for Lymphoma The Lymphoma Research Foundation is nothing without its philanthropic supporters. For three decades, we have built a community rooted in research and strengthened by compassion and care,…
Redefining the Journey: How Lymphoma Survivorship Has Transformed Over Time When the Lymphoma Research Foundation was founded in 1995, the outcomes post-lymphoma diagnosis—and the resources available for cancer survivors and their loved ones—looked very different. With the advent of lifespan-expanding…
Is Lymphoma a Blood Cancer? Most people are familiar with the word cancer—and many have even heard the term blood cancer. However, lymphoma might be a term less familiar to some, despite it being one of the most common blood…
Blood Cancer Awareness Month: Standing Together, Leading the Lymphoma Community Every September, the lymphoma community comes together to celebrate Blood Cancer Awareness Month (BCAM) and World Lymphoma Awareness Day (September 15)—a powerful time to honor the resilience of our community…
The Lymphoma Research Foundation – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives, and patient services – today announced the election of Kristi Hendriks of Boston, MA to its Board of Directors.
The Lymphoma Research Foundation – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives, and patient services – today announced the election of Kristi Hendriks of Boston, MA to its Board of Directors.
Lymphoma Research Foundation Celebrates 30 Years of Impact, Innovation, and Hope Foundation celebrates 30 years of advancing research, empowering the lymphoma community, and driving toward a future without lymphoma. The Lymphoma Research Foundation, the nation’s largest non-profit organization dedicated exclusively…
Practicing Self-Care and Mindfulness as a Care Partner When you’re a care partner for a lymphoma patient, the needs and well-being of someone else become your top priority as you support them through their diagnosis. It’s important to remember that with…
Lymphoma Research Foundation Elects Chair Andrew Evens, DO, MBA, MSc Scientific Advisory Board Chair Physician researcher and clinical expert in the field of lymphoid malignancies elected to lead prestigious Scientific Advisory Board; Foundation also welcomes four new members to the…
On June 18, 2025, the U.S. Food and Drug Administration (FDA) announced it has granted accelerated approval of tafasitamab-cxix (Monjuvi, Incyte Corporation) with lenalidomide and rituximab for adults with relapsed or refractory follicular lymphoma (FL). Tafasitamab-cxix is a monoclonal antibody. Monoclonal…
